Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth

• Главные авторы: Zhiqin Li (Автор), Jianxia Dong (Автор), Meng Wang (Автор), Jingya Yan (Автор), Yushu Hu (Автор), Yang Liu (Автор), Yajie Pan (Автор), Hua Li (Автор)
• Формат: ‌
• Опубликовано: BMC, 2022-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background The altered gut microbiota is implicated in the pathogenesis of liver fibrosis. Resveratrol is a candidate for the treatment of liver fibrosis, which could ameliorate the dysregulation of gut microbiota in mice. This study aimed to clarify the role and mechanism of resveratrol in...